ERAS Protocols in Breast Conserving Surgery

Abroad (travel likely)Recruiting

Conditions

Breast Cancer · Postoperative Recovery

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Nebraska Medical Center, Omaha, Nebraska, United States
Contact: Study coordinator (Rubayat I Khan, PhD) · rubayat.khan@unmc.edu · 402-559-2983
Contact: Study coordinator (Taylor A Johnson, MA) · taylora.johnson@unmc.edu · 402-559-5669
Contact: Principal Investigator (Juan A Santamaria, MD)

Study leads

Juan A Santamaria, MD
Principal Investigator
University of Nebraska

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

Advanced Solid Tumor · Advanced Breast Cancer · Advanced Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1

Birmingham, United States · Fullerton, United States

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

HR+/HER2- Breast Cancer

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Anchorage, United States

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

High Grade Epithelial Ovarian Cancer · High Grade Serous Ovarian Cancer · Primary Peritoneal Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Phoenix, United States · Tucson, United States

A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer

HER2-positive Breast Cancer

Abroad (travel likely)RecruitingPHASE3

Bengbu, China · Fuyang, China